A new information-sharing agreement is designed to give the SEC and FDA a more complete picture of what companies are telling regulators and investors

The Federal Drive with Terry Gerton · 4 ноября 2026 г. · 9 мин

When companies operate under both FDA and SEC oversight, regulators sometimes need a clearer picture of the same set of facts. An updated agreement is designed to support information sharing between the agencies when those situations arise. For what it means for regulated companies and investors alike, I'm joined by Tom Sundloff, partner at Blank Rome. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info .